GuideAI Health Valuation Multiples

GuideAI Health is valued at $45M as of September 2026. In the last FY GuideAI Health reported revenue of - and EBITDA of ($846K).

GuideAI Health Overview

About GuideAI Health

GuideAI Health Corp is a healthcare technology company using artificial intelligence to enable the early detection of vascular disease and support more precise treatment decisions. Its platform analyzes routine CT scans to identify peripheral vascular disease and other vascular conditions that are frequently missed or under-reported, generating structured, actionable reports for radiologists and treating clinicians. By surfacing disease earlier and matching findings to appropriate treatment pathways, it aims to improve patient outcomes while helping hospitals and radiology groups deliver more comprehensive vascular care. Its Platform Capabilities are AI-powered vascular imaging, Early detection of disease, subtle patterns and risk signals, Structured, consistent AI-generated, and Others.


Founded

2025

HQ

Canada

Employees

N/A

Financials (FY)

Revenue: -
EBITDA: ($846K)

EV

$48M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

GuideAI Health Financials

GuideAI Health reported last fiscal year revenue of - and negative EBITDA of ($846K).

In the same fiscal year, GuideAI Health generated ($846K) in EBITDA losses and had net loss of ($882K).


GuideAI Health P&L

In the most recent fiscal year, GuideAI Health reported revenue of - and EBITDA of ($846K).

GuideAI Health is unprofitable as of last fiscal year, with EBITDA margin of - and net margin of -.

See analyst estimates for GuideAI Health
Last FY202320242025202620272028
EBITDA($846K)($82K)($504K)($846K)
Net Profit($882K)($83K)($523K)($882K)
Net Debt$881K---

Financial data powered by Morningstar, Inc.

GuideAI Health Stock Performance

GuideAI Health has current market cap of $45M, and enterprise value of $48M.

Market Cap Evolution


GuideAI Health's stock price is $0.85.

GuideAI Health share price decreased by 2.5% in the last 30 days.

GuideAI Health has an EPS (earnings per share) of $-0.02.

See more trading valuation data for GuideAI Health
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$48M$45M-0.3%-2.5%-16.5%-$-0.02

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

GuideAI Health Valuation Multiples

GuideAI Health trades at (56.3x) EV/EBITDA.

See NTM and 2027E valuation multiples for GuideAI Health

GuideAI Health Financial Valuation Multiples

As of September 18, 2026, GuideAI Health has market cap of $45M and EV of $48M.

GuideAI Health has a P/E ratio of (51.4x).

Last FY202320242025202620272028
EV/EBITDA(56.3x)n/m(94.5x)(56.3x)
EV/EBIT(56.3x)n/m(94.5x)(56.3x)
P/E(51.4x)n/m(86.5x)(51.4x)
EV/FCF(66.3x)n/m(113.0x)(66.3x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified GuideAI Health Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

GuideAI Health Margins & Growth Rates

See estimated margins and future growth rates for GuideAI Health

GuideAI Health Growth Rates

23/2424/2526/2727/2828/29
EBITDA Growth518%68%
EBIT Growth518%68%
Net Profit Growth532%68%
FCF Growth570%70%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

GuideAI Health Competitors

GuideAI Health competitors include Redwood AI, Vuno, Cyclopharm, MeVis, Elliptic Laboratories, Novacyt, Chandan Healthcare, Klea, Diagnos and Deepnoid.

Most GuideAI Health public comparables operate across Medical Imaging & Diagnostics, Vertical AI Applications, HealthTech and Vertical SaaS.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Redwood AI-($385K)--(113.3x)-
Vuno$25M($3M)1.0x-(9.5x)-
Cyclopharm$12M($11M)3.3x1.6x(3.5x)(3.7x)
MeVis$18M$4M2.4x-11.6x-
Elliptic Laboratories$11M($4M)4.2x4.3x(12.1x)(65.6x)
Novacyt$27M($29M)1.1x1.1x(1.0x)(2.8x)
Chandan Healthcare$29M$5M1.9x-10.7x-
Klea$26M$6M2.0x-8.7x-

This data is available for Pro users. Sign up to see all GuideAI Health competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About GuideAI Health

When was GuideAI Health founded?GuideAI Health was founded in 2025.
Where is GuideAI Health headquartered?GuideAI Health is headquartered in Canada.
Is GuideAI Health publicly listed?Yes, GuideAI Health is a public company listed on NEO Exchange.
What is the stock symbol of GuideAI Health?GuideAI Health trades under GDAI ticker.
When did GuideAI Health go public?GuideAI Health went public in 2026.
Who are competitors of GuideAI Health?GuideAI Health main competitors include Redwood AI, Vuno, Cyclopharm, MeVis, Elliptic Laboratories, Novacyt, Chandan Healthcare, Klea, Diagnos, Deepnoid.
What is the current market cap of GuideAI Health?GuideAI Health's current market cap is $45M.
Is GuideAI Health profitable?No, GuideAI Health is not profitable.
How many companies GuideAI Health has acquired to date?GuideAI Health hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies GuideAI Health has invested to date?GuideAI Health hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to GuideAI Health

Lists including GuideAI Health

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial